Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amerlioration of Opioid Withdrawal-Induced Anxiety and Craving With Heterodyned Whole-Body Vibration (HWBV)

NCT05056753 is registered in ClinicalTrials.gov with PhotoPharmics, Inc. as lead sponsor.

NCT NCT05056753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05056753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amerlioration of Opioid Withdrawal-Induced Anxiety and Craving With Heterodyned Whole-Body Vibration (HWBV)
Lead sponsor
PhotoPharmics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 20, 2022
Completion date
July 30, 2023
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-use disorder